GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 19th Apr 2024 ABUS stock ended at $2.72. This is 0.366% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 6.04% from a day low at $2.65 to a day high of $2.81.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2020-10-23 $2.88 $2.91 $2.77 $2.89 825 527
2020-10-22 $2.79 $2.93 $2.79 $2.91 1 033 652
2020-10-21 $2.89 $2.93 $2.79 $2.79 1 161 093
2020-10-20 $3.02 $3.05 $2.88 $2.88 1 156 717
2020-10-19 $3.08 $3.10 $2.95 $3.00 1 251 498
2020-10-16 $3.08 $3.14 $3.04 $3.07 874 384
2020-10-15 $3.10 $3.14 $3.04 $3.09 968 990
2020-10-14 $3.22 $3.32 $3.12 $3.16 1 085 309
2020-10-13 $3.16 $3.33 $3.16 $3.27 1 108 912
2020-10-12 $3.17 $3.22 $3.08 $3.19 996 816
2020-10-09 $3.16 $3.23 $3.12 $3.20 823 975
2020-10-08 $3.39 $3.44 $3.13 $3.14 1 639 013
2020-10-07 $3.10 $3.38 $3.09 $3.32 1 644 768
2020-10-06 $3.26 $3.30 $3.03 $3.07 1 075 203
2020-10-05 $3.04 $3.26 $3.00 $3.26 1 491 639
2020-10-02 $3.00 $3.13 $2.97 $3.02 1 254 370
2020-10-01 $3.17 $3.17 $3.06 $3.09 659 583
2020-09-30 $3.17 $3.20 $3.06 $3.13 861 779
2020-09-29 $3.01 $3.24 $2.95 $3.18 1 305 446
2020-09-28 $3.12 $3.13 $2.95 $3.03 968 584
2020-09-25 $2.93 $3.14 $2.93 $3.08 1 070 094
2020-09-24 $2.89 $2.98 $2.85 $2.92 1 910 496
2020-09-23 $3.01 $3.05 $2.87 $2.94 1 474 274
2020-09-22 $3.03 $3.07 $2.90 $3.03 1 207 449
2020-09-21 $3.09 $3.10 $2.91 $3.03 1 987 613
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT